Starting Dose for Severe Psychosis with Risperidone
For adults with severe psychosis, start risperidone at 2 mg/day, which is the FDA-approved initial dose for schizophrenia. 1
Dosing Algorithm
Initial Dosing
- Start: 2 mg/day (can be given once daily or divided into twice-daily dosing) 1
- Titration: Increase at intervals of at least 24 hours, in increments of 1-2 mg/day as tolerated 1
- Target range: 4-8 mg/day for most adults with schizophrenia 1
Important Context: "Severe Psychosis" Does Not Mean Higher Starting Doses
A critical pitfall is assuming that "severe" psychosis requires higher initial doses. The evidence strongly contradicts this approach. The FDA label clearly states that doses above 6 mg/day were not more efficacious than lower doses and were associated with more extrapyramidal symptoms 1. In fact, research demonstrates that even 2 mg/day can be highly effective for acute psychotic symptoms 2, 3.
Special Considerations for First-Episode Psychosis
If this is a first psychotic episode, the dosing should be even more conservative:
- Start: 0.5-1 mg/day 4
- Target: 2 mg/day (international guidelines recommend this as the initial target dose) 4
- Maximum typically needed: 3-4 mg/day 4
The 2005 International Clinical Practice Guidelines for Early Psychosis specifically recommend risperidone 2 mg/day as an appropriate initial target dose for first-episode patients, with a maximum of 4 mg/day 4. Research confirms that 2 mg/day is highly effective in first-episode psychosis, with 62-80% response rates 2, 3.
Elderly or Frail Patients
For elderly patients or those with dementia-related behavioral disturbances:
- Start: 0.25 mg/day at bedtime 5
- Maximum: 2-3 mg/day (usually divided twice daily) 5
- Caution: Extrapyramidal symptoms may occur at 2 mg/day in this population 5
Acute Agitation Management
For severe psychotic agitation requiring rapid tranquilization:
- Delirium context: 0.5 mg PO stat (can repeat up to every 12 hours as needed) 6
- Note: Higher doses do not provide faster or better control and increase adverse effects 7, 8
Key Evidence Supporting Lower Doses
The most recent and highest-quality guideline (2025 INTEGRATE guidelines) emphasizes starting with therapeutic doses but avoiding supersaturation of D2 receptors 9. PET imaging studies demonstrate that risperidone 4 mg/day achieves optimal D2 receptor occupancy (70-80%), while 6 mg/day causes unnecessarily high occupancy (>80%) with increased extrapyramidal side effects 10.
Research consistently shows that 2-4 mg/day is effective for acute psychosis 11, 2, 3, 12. A 2001 review concluded that the target dose should be 4 mg/day for most patients, with lower doses appropriate for first-episode and elderly patients 11. Multiple studies in first-episode psychosis found no efficacy advantage for doses above 2-3 mg/day 2, 3, 12.
Critical Warnings
- Do not use higher starting doses for "severe" symptoms - this increases adverse effects without improving efficacy 1, 7
- Avoid rapid escalation - allow at least 24 hours between dose increases 1
- Monitor for extrapyramidal symptoms - these increase significantly above 6 mg/day 1, 10
- Slower titration may be appropriate for many patients 1
Assessment Timeline
- Evaluate response at 4 weeks at a therapeutic dose before considering switching 9
- Do not prematurely escalate - adequate time at each dose level is essential 9
The evidence strongly supports starting conservatively at 2 mg/day for adults with severe psychosis, regardless of symptom severity, with careful titration based on response and tolerability rather than symptom intensity.